Department of Orthopaedic Surgery and Traumatology. "Maggiore" Hospital of Chieri. Turin. ITA.
Department of nephrology and dialysis, "Regina Margherita" Hospital Turin. ITA.
Acta Biomed. 2020 May 11;91(2):342-349. doi: 10.23750/abm.v91i2.8188.
Osteonecrosis of the femoral head (ONFH) is a frequent orthopedic disease leading to destruction of the hip joint and disabling arthritis. Several procedures have been developed to treat the joint deterioration in case of osteonecrosis, trying to avoid or delay an intervention of total hip replacement, especially in young patients. The aim of this study was to analyze the use of autologous bone micrografts derived from cancellous bone in the management of avascular ONFH. The treatment described was implemented using the Rigenera® protocol to obtain autologous micrografts: small fragments of cancellous bone collected by femoral neck, disaggregated and injected in the necrotic area using an empty screw.
Twenty adult patients affected by avascular ONFH were enrolled in this study; all patients reported a preoperative intermittent coxo-arthrosis and limited function of intra and extra rotation of the hip. Inclusion criteria were an Oxford Hip Score between (OHS) 20 and 39, a Harris hip score (HHS) showing pre-operative poor results (lower than 70 points) and a stage II-IIIA and IIIB according with the classification proposed by the Association Research Circulation Osseous (ARCO).
Using an MRI evaluation, after six months, the authors observed a complete regression of necrotic area and the restoration of osseous structure. Clinical outcome has been evaluated at 6-12 and 24 months follow-up. At the final F.U. the HHS rised from poor to good results (mean value at final F.U of 84) while the OHS improved significantly already after 21 days from micrografts injection (mean 35.4 ± 7.5) with an increasing trend until to two-year final FU (mean 37.4 ± 9.5). The full recovery of daily and mild sport activities was reached after 20 and 90 days from intervention, respectively.
The results of this study are suggestive for a new approach in the treatment of avascular ONFH assuming a process of bone regeneration based on a dual mechanism of action, biological and mechanical, induced by micrografts and injected using an empty screw as vehicle.
股骨头坏死(ONFH)是一种常见的骨科疾病,可导致髋关节破坏和致残性关节炎。已经开发了几种手术来治疗骨坏死引起的关节恶化,试图避免或延迟全髋关节置换术,特别是在年轻患者中。本研究的目的是分析使用松质骨来源的自体骨微移植物治疗缺血性股骨头坏死。所描述的治疗是使用 Rigenera®方案来获得自体微移植物来实施的:通过股骨颈收集小块的松质骨,将其分散并使用空螺钉注入坏死区域。
本研究纳入了 20 例成人缺血性股骨头坏死患者;所有患者均报告术前间歇性髋关节病和髋关节内、外旋转功能受限。纳入标准为 Oxford 髋关节评分(OHS)为 20-39 分,Harris 髋关节评分(HHS)显示术前结果较差(低于 70 分),根据 Association Research Circulation Osseous(ARCO)提出的分类为 II 期-IIIA 期和 IIIB 期。
通过 MRI 评估,在 6 个月后,作者观察到坏死区域完全消退,骨结构恢复。在 6-12 个月和 24 个月的随访中评估了临床结果。在最终随访时,HHS 从较差变为较好(最终随访时的平均 HHS 为 84),而 OHS 在微移植物注射后 21 天内显著改善(平均 35.4±7.5),直到 2 年最终随访时呈上升趋势(平均 37.4±9.5)。在干预后 20 天和 90 天,分别恢复了日常和轻度运动活动。
本研究结果提示,对于缺血性股骨头坏死的治疗,可以采用一种新的方法,假设基于微移植物的生物和机械双重作用的骨再生过程,使用空螺钉作为载体注入微移植物。